In the current study, we show that DNA-PKcs is over-expressed in multiple human RCC tissues and cells, regulating mTOR complex 2 (mTORC2)-AKT activation, hypoxia-inducible factor-2α (HIF-2α) expression and RCC cell progression. This evidence concerns the gene EPAS1 and renal cell carcinoma.